Evidence map›Paper›PMID 40928972›Full record

ArticleeLife2025

p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partners.

Anamari Brdar, Christian Osterburg, Philipp Münick, Anne Christin Machel, Rajeshwari Rathore, Susanne Osterburg, Büşra Yüksel, Birgit Schäfer, Kristina Desch, Julian D Langer and 2 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anamari Brdar *Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.
Christian Osterburg *Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.
Philipp Münick *Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0002-0548-0897
Anne Christin MachelInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.
Rajeshwari RathoreInstitute of Biochemistry II, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.
Susanne OsterburgInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.
Büşra YükselInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.
Birgit SchäferInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.
Kristina DeschMax Planck Institute for Brain Research, Frankfurt, Germany.
Julian D LangerMax Planck Institute of Biophysics, Frankfurt, Germany.ORCID https://orcid.org/0000-0002-5190-577X
Ivan DikicInstitute of Biochemistry II, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0001-8156-9511
Volker DötschInstitute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0001-5720-212X

Funding

Deutsche Krebshilfe 70113956Hessian Ministry of Arts for Science and the Arts Clusterproject ENABLE
6 · The paper itself

Abstract

The p53 transcription factor family consists of the three members p53, p63, and p73. Both p63 and p73 exist in different isoforms that are well characterized. Isoforms have also been identified for p53 and it has been proposed that they are responsible for increased cancer metastasis. In contrast to the p63 and p73 isoforms, which do not contain truncations in folded domains, most of the p53 isoforms contain only parts of either the DNA-binding domain (DBD) or the oligomerization domain. To better understand the effect of p53 isoforms in cancer, we provide here a comprehensive biochemical characterization. With the exception of the Δ40p53α isoform, none of the other variants can bind to DNA with high affinity and none can upregulate transcription. Probing with antibodies, DARPins and other interaction partners confirmed that isoforms harbouring deletions in the DBD cannot interact specifically with them, but instead are bound to chaperones and other factors known to interact with misfolded proteins. Expression of isoforms with deletions in the DBD results in upregulation of cellular chaperones. If the expression level surpasses a threshold, the chaperone system can no longer keep these isoforms soluble, resulting in aggregation and co-aggregation with other factors.

Indexed as

Molecular ChaperonesProtein AggregatesTumor Suppressor Protein p53DNAHumansProtein BindingProtein IsoformsDNAMolecular ChaperonesProtein AggregatesProtein IsoformsTP53 protein, humanTumor Suppressor Protein p53aggregationhumanmolecular biophysicsp53 familyp53 isoformsstructural biology

Identifiers

PMID40928972
PMCPMC12422735

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.